News

Shares of Amgen Inc. AMGN rallied 1.03% to $280.35 Wednesday, on what proved to be an all-around mixed trading session for ...
Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...
Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...
To get a sense of who is truly in control of Amgen Inc. (NASDAQ:AMGN), it is important to understand the ownership structure of the business. The group holding the most number of shares in the company ...
A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...
The once-monthly drug is still under study but could provide added convenience and another option for patients.
If the drug is more broadly used in people with obesity and not just diabetes, those with higher body weights may see even ...
Retired pro football hall-of-famer Barry Sanders revealed he had a heart attack in 2024. But now he working to help other ...
Zacks Investment Research on MSN7h
Here's Why Amgen (AMGN) is a Strong Value Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Keurig Dr Pepper Inc. (NASDAQ:KDP) is one of the 12 stocks on Jim Cramer’s radar recently. A caller asked if the company ...
Regeneron is hoping a new program will widen patient access to its eye drug without also benefiting the company's rivals — a ...